As of Feb 27
| -0.04 / -1.54%|
The 3 analysts offering 12-month price forecasts for IntelliPharmaCeutics International Inc have a median target of 8.00, with a high estimate of 11.00 and a low estimate of 7.00. The median estimate represents a +213.73% increase from the last price of 2.55.
The current consensus among 3 polled investment analysts is to Buy stock in IntelliPharmaCeutics International Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.